ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 617

$770K Total Retail Price of All Prescriptions

Rank: 14 out of 617

622 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 5,123 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 520 135 S3 1 8
OMEPRAZOLE 478 183 2 3
LISINOPRIL 390 152 3 5
GABAPENTIN 360 191 4 16
FUROSEMIDE 359 177 5 4
SIMVASTATIN 323 137 6 2
LEVOTHYROXINE SODIUM 320 165 7 1
METFORMIN HCL 293 86 8 9
PRAVASTATIN SODIUM 290 103 9 21
AMLODIPINE BESYLATE 288 139 10 6
GLIMEPIRIDE 215 85 11 33
WARFARIN SODIUM 209 113 12 7
METOPROLOL TARTRATE 188 109 13 11
ATENOLOL 187 91 14 17
POTASSIUM CHLORIDE 186 71 15 10
ZOLPIDEM TARTRATE 176 45 16 23
CYMBALTA 171 65 17 49
FAMOTIDINE 164 81 18 54
TRAMADOL HCL 163 37 19 15
CRESTOR 158 40 20 28
ATORVASTATIN CALCIUM 141 48 21 14
CARVEDILOL 140 85 22 19
HYDROCHLOROTHIAZIDE 139 70 23 13
FLUOXETINE HCL 130 64 24 73
CYCLOBENZAPRINE HCL 130 17 R 24 74
PROAIR HFA 129 40 26 75
MELOXICAM 127 41 27 24
CLONIDINE HCL 126 54 28 55
SERTRALINE HCL 117 75 29 20
IBUPROFEN 114 29 30 140
OXYCODONE HCL 112 47 S2 31 130
METOPROLOL SUCCINATE 107 49 32 12
LANTUS SOLOSTAR 98 16 33 115
SPIRIVA 95 42 34 61
TRICOR 92 0 35 83
GEMFIBROZIL 90 17 36 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 52 37 29
TRAZODONE HCL 88 0 38 51
ADVAIR DISKUS 83 22 39 38
TIZANIDINE HCL 80 0 40 180
TRIAMTERENE-HCTZ 80 18 40 47
CITALOPRAM HBR 80 41 40 18
PANTOPRAZOLE SODIUM 79 22 43 37
NEXIUM 78 33 44 43
AMITRIPTYLINE HCL 75 35 R 45 56
LANTUS 75 28 45 39
TRIAMCINOLONE ACETONIDE 75 55 45 102
FLUTICASONE PROPIONATE 73 21 48 36
ROPINIROLE HCL 69 13 49 66
OXYCODONE-ACETAMINOPHEN 68 23 S2 50 93
NAPROXEN 66 14 51 101
PREMARIN 64 29 R 52 108
BUSPIRONE HCL 61 25 53 131
BUPROPION HCL SR 57 21 54 202
OXYBUTYNIN CHLORIDE 57 30 54 88
POLYETHYLENE GLYCOL 3350 57 24 54 32
SINGULAIR 56 17 57 106
GLIPIZIDE 56 0 57 82
METFORMIN HCL ER 54 31 59 72
CEPHALEXIN 53 24 60 68
ABILIFY 51 0 61 131
VENTOLIN HFA 51 0 61 200
BACLOFEN 51 0 61 146
AZITHROMYCIN 51 15 61 70
LOSARTAN POTASSIUM 50 31 65 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.